Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.10.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.41.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCKNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JY.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.7.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.501NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.226NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.546NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.194NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.429.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.9 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.25.1.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.203NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.176NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.3.4 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.391NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.432NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.388NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used